ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
20 Dec 2021

Acarix announce final outcome in rights issue

Press release Malmö, December 20, 2021 Acarix announce final outcome in rights issue Acarix AB ("Acarix" or the "Company") has c...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
20 Dec 2021

Acarix offentliggör slutgiltigt utfall i företrädesemission

Press release Malmö, 20 december, 2021 Acarix offentliggör slutgiltigt utfall i företrädesemission Acarix AB ("A...
Continue reading
author-avatar acarix
Corporate Action, IR, Listing Regulation, News, Prospectus, Regulatory, Swedish
November 18, 2024
30 Nov 2021

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK

Acarix offentliggör prospekt i samband med företrädesemission om cirka 79 MSEK Extra bolagsstämman i Acarix AB ("A...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Prospectus, Regulatory
November 18, 2024
30 Nov 2021

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million

Acarix publishes prospectus in connection with rights issue of approximately SEK 79 million The Extraordinary General Meeting of Acari...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish
November 18, 2024
23 Nov 2021

Kommuniké från extra bolagsstämma i Acarix

Press release Malmö, 23 november, 2021 Kommuniké från extra bolagsstämma i Acarix Extra bolagsstämma i A...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
23 Nov 2021

Announcement from Acarix’s extra general meeting

Press release Malmö, November 23, 2021 Announcement from Acarix's extra general meeting The extra general meeting of Acarix AB (...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Q3, Regulatory, Report
November 18, 2024
11 Nov 2021

Acarix AB (publ) publishes Interim Report, January – September 2021

Press release Malmö, November 11, 2021 Acarix AB (publ) publishes Interim Report, January – September 2021 Positive trend ...
Continue reading
author-avatar acarix
Interim, IR, Listing Regulation, News, Q3, Regulatory, Report, Swedish
November 18, 2024
11 Nov 2021

Acarix AB (publ) publicerar delårsrapport, januari – september 2021

Press release Malmö, 11 november, 2021 Acarix AB (publ) publicerar delårsrapport, januari – september 2021 Posit...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
09 Nov 2021

Acarix accelerates US market entry with Proximo Medical as commercialization partner

  Press release (MAR)Malmö, Sweden, November 9, 2021 Acarix accelerates US market entry with Proximo Medical as commerciali...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
08 Nov 2021

Acarix US expansion to be a major contributor to the company’s new financial and operational goals

Press release (MAR)Malmö, Sweden, November 8, 2021 Acarix US expansion to be a major contributor to the company’s new fina...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Notice, Regulatory, Swedish
November 18, 2024
05 Nov 2021

Kallelse till extra bolagsstämma i Acarix AB

Kallelse till extra bolagsstämma i Acarix AB Aktieägarna i Acarix AB, org. nr 559009-0667, ("Bolaget") kallas härmed ti...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
05 Nov 2021

Notice of Extra General Meeting in Acarix AB

Notice of Extra General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened...
Continue reading
  • «
  • ‹
  • 20
  • 21
  • 22
  • 23
  • 24
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.